- call +1-201-465-4211
- email sales@mrinsights.biz
Anticoagulants, commonly referred to as blood thinners, are substances that prevent or reduce coagulation of blood, prolonging the clotting time. Some of them occur naturally in blood-eating animals such as leeches and mosquitoes, where they help keep the bite area unclotted long enough for the animal to obtain some blood. As a class of medications, anticoagulants are used in therapy for thrombotic disorders. Oral anticoagulants (OACs) are taken by many people in pill or tablet form, and various intravenous anticoagulant dosage forms are used in hospitals. Some anticoagulants are used in medical equipment, such as test tubes, serum-separating tubes, blood transfusion bags, and dialysis equipment.
Scope of the Report:
Anticoagulants, commonly referred to as blood thinners, are substances that prevent or reduce coagulation of blood, prolonging the clotting time. Some of them occur naturally in blood-eating animals such as leeches and mosquitoes, where they help keep the bite area unclotted long enough for the animal to obtain some blood. As a class of medications, anticoagulants are used in therapy for thrombotic disorders. Oral anticoagulants (OACs) are taken by many people in pill or tablet form, and various intravenous anticoagulant dosage forms are used in hospitals. Some anticoagulants are used in medical equipment, such as test tubes, serum-separating tubes, blood transfusion bags, and dialysis equipment.
Anticoagulants are widely used for VTE, ACS/MI, AF and other field. The most proportion of anticoagulants used to treat AF, and the revenue in 2016 is 13118 M USD.
Europe region is the largest supplier of anticoagulants, with a production market share nearly 56.40% in 2016. North America is the second largest supplier of anticoagulants, enjoying production market share nearly 26.35% in 2016.
The worldwide market for Anticoagulants is expected to grow at a CAGR of roughly 8.8% over the next five years, will reach 1230 million US$ in 2024, from 740 million US$ in 2019, according to a new study.
This report focuses on the Anticoagulants in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
Sanofi
Bayer
Boehringer Ingelheim
Johnson & Johnson
Genentech (Roche)
AstraZeneca
Bristol-Myers Squibb
Aspen
Lilly
Otsuka
Pfizer
Daiichi Sankyo
The Medicines Company
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Platelet aggregation inhibitors (PAI)
Low-molecular-weight Heparin (LMWH)
Direct thrombin inhibitor (DTI)
Direct factor Xa inhibitors (DFXa)
Vitamin K antagonists (VKA)
Others
Market Segment by Applications, can be divided into
VTE
ACS/MI
AF
Other
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Anticoagulants product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Anticoagulants, with price, sales, revenue and global market share of Anticoagulants in 2017 and 2018.
Chapter 3, the Anticoagulants competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Anticoagulants breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Anticoagulants market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Anticoagulants sales channel, distributors, customers, research findings and conclusion, appendix and data source.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 Anticoagulants Introduction
1.2 Market Analysis by Type
1.2.1 Platelet aggregation inhibitors (PAI)
1.2.2 Low-molecular-weight Heparin (LMWH)
1.2.3 Direct thrombin inhibitor (DTI)
1.2.4 Direct factor Xa inhibitors (DFXa)
1.2.5 Vitamin K antagonists (VKA)
1.2.6 Others
1.3 Market Analysis by Applications
1.3.1 VTE
1.3.2 ACS/MI
1.3.3 AF
1.3.4 Other
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2014-2024)
1.4.1.2 Canada Market States and Outlook (2014-2024)
1.4.1.3 Mexico Market States and Outlook (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2014-2024)
1.4.2.2 France Market States and Outlook (2014-2024)
1.4.2.3 UK Market States and Outlook (2014-2024)
1.4.2.4 Russia Market States and Outlook (2014-2024)
1.4.2.5 Italy Market States and Outlook (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2014-2024)
1.4.3.2 Japan Market States and Outlook (2014-2024)
1.4.3.3 Korea Market States and Outlook (2014-2024)
1.4.3.4 India Market States and Outlook (2014-2024)
1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2014-2024)
1.4.4.2 Egypt Market States and Outlook (2014-2024)
1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
1.4.4.4 South Africa Market States and Outlook (2014-2024)
1.4.4.5 Turkey Market States and Outlook (2014-2024)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Sanofi
2.1.1 Business Overview
2.1.2 Anticoagulants Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Sanofi Anticoagulants Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.2 Bayer
2.2.1 Business Overview
2.2.2 Anticoagulants Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Bayer Anticoagulants Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.3 Boehringer Ingelheim
2.3.1 Business Overview
2.3.2 Anticoagulants Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Boehringer Ingelheim Anticoagulants Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.4 Johnson & Johnson
2.4.1 Business Overview
2.4.2 Anticoagulants Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Johnson & Johnson Anticoagulants Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.5 Genentech (Roche)
2.5.1 Business Overview
2.5.2 Anticoagulants Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Genentech (Roche) Anticoagulants Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.6 AstraZeneca
2.6.1 Business Overview
2.6.2 Anticoagulants Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 AstraZeneca Anticoagulants Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.7 Bristol-Myers Squibb
2.7.1 Business Overview
2.7.2 Anticoagulants Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Bristol-Myers Squibb Anticoagulants Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.8 Aspen
2.8.1 Business Overview
2.8.2 Anticoagulants Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Aspen Anticoagulants Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.9 Lilly
2.9.1 Business Overview
2.9.2 Anticoagulants Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Lilly Anticoagulants Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.10 Otsuka
2.10.1 Business Overview
2.10.2 Anticoagulants Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Otsuka Anticoagulants Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.11 Pfizer
2.11.1 Business Overview
2.11.2 Anticoagulants Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Pfizer Anticoagulants Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.12 Daiichi Sankyo
2.12.1 Business Overview
2.12.2 Anticoagulants Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 Daiichi Sankyo Anticoagulants Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.13 The Medicines Company
2.13.1 Business Overview
2.13.2 Anticoagulants Type and Applications
2.13.2.1 Product A
2.13.2.2 Product B
2.13.3 The Medicines Company Anticoagulants Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
3 Global Anticoagulants Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)
3.1 Global Anticoagulants Sales and Market Share by Manufacturer (2017-2018)
3.2 Global Anticoagulants Revenue and Market Share by Manufacturer (2017-2018)
3.3 Market Concentration Rate
3.3.1 Top 3 Anticoagulants Manufacturer Market Share in 2018
3.3.2 Top 6 Anticoagulants Manufacturer Market Share in 2018
3.4 Market Competition Trend
4 Global Anticoagulants Market Analysis by Regions
4.1 Global Anticoagulants Sales, Revenue and Market Share by Regions
4.1.1 Global Anticoagulants Sales and Market Share by Regions (2014-2019)
4.1.2 Global Anticoagulants Revenue and Market Share by Regions (2014-2019)
4.2 North America Anticoagulants Sales and Growth Rate (2014-2019)
4.3 Europe Anticoagulants Sales and Growth Rate (2014-2019)
4.4 Asia-Pacific Anticoagulants Sales and Growth Rate (2014-2019)
4.5 South America Anticoagulants Sales and Growth Rate (2014-2019)
4.6 Middle East and Africa Anticoagulants Sales and Growth Rate (2014-2019)
5 North America Anticoagulants by Country
5.1 North America Anticoagulants Sales, Revenue and Market Share by Country
5.1.1 North America Anticoagulants Sales and Market Share by Country (2014-2019)
5.1.2 North America Anticoagulants Revenue and Market Share by Country (2014-2019)
5.2 United States Anticoagulants Sales and Growth Rate (2014-2019)
5.3 Canada Anticoagulants Sales and Growth Rate (2014-2019)
5.4 Mexico Anticoagulants Sales and Growth Rate (2014-2019)
6 Europe Anticoagulants by Country
6.1 Europe Anticoagulants Sales, Revenue and Market Share by Country
6.1.1 Europe Anticoagulants Sales and Market Share by Country (2014-2019)
6.1.2 Europe Anticoagulants Revenue and Market Share by Country (2014-2019)
6.2 Germany Anticoagulants Sales and Growth Rate (2014-2019)
6.3 UK Anticoagulants Sales and Growth Rate (2014-2019)
6.4 France Anticoagulants Sales and Growth Rate (2014-2019)
6.5 Russia Anticoagulants Sales and Growth Rate (2014-2019)
6.6 Italy Anticoagulants Sales and Growth Rate (2014-2019)
7 Asia-Pacific Anticoagulants by Country
7.1 Asia-Pacific Anticoagulants Sales, Revenue and Market Share by Country
7.1.1 Asia-Pacific Anticoagulants Sales and Market Share by Country (2014-2019)
7.1.2 Asia-Pacific Anticoagulants Revenue and Market Share by Country (2014-2019)
7.2 China Anticoagulants Sales and Growth Rate (2014-2019)
7.3 Japan Anticoagulants Sales and Growth Rate (2014-2019)
7.4 Korea Anticoagulants Sales and Growth Rate (2014-2019)
7.5 India Anticoagulants Sales and Growth Rate (2014-2019)
7.6 Southeast Asia Anticoagulants Sales and Growth Rate (2014-2019)
8 South America Anticoagulants by Country
8.1 South America Anticoagulants Sales, Revenue and Market Share by Country
8.1.1 South America Anticoagulants Sales and Market Share by Country (2014-2019)
8.1.2 South America Anticoagulants Revenue and Market Share by Country (2014-2019)
8.2 Brazil Anticoagulants Sales and Growth Rate (2014-2019)
8.3 Argentina Anticoagulants Sales and Growth Rate (2014-2019)
8.4 Colombia Anticoagulants Sales and Growth Rate (2014-2019)
9 Middle East and Africa Anticoagulants by Countries
9.1 Middle East and Africa Anticoagulants Sales, Revenue and Market Share by Country
9.1.1 Middle East and Africa Anticoagulants Sales and Market Share by Country (2014-2019)
9.1.2 Middle East and Africa Anticoagulants Revenue and Market Share by Country (2014-2019)
9.2 Saudi Arabia Anticoagulants Sales and Growth Rate (2014-2019)
9.3 Turkey Anticoagulants Sales and Growth Rate (2014-2019)
9.4 Egypt Anticoagulants Sales and Growth Rate (2014-2019)
9.5 Nigeria Anticoagulants Sales and Growth Rate (2014-2019)
9.6 South Africa Anticoagulants Sales and Growth Rate (2014-2019)
10 Global Anticoagulants Market Segment by Type
10.1 Global Anticoagulants Sales, Revenue and Market Share by Type (2014-2019)
10.1.1 Global Anticoagulants Sales and Market Share by Type (2014-2019)
10.1.2 Global Anticoagulants Revenue and Market Share by Type (2014-2019)
10.2 Platelet aggregation inhibitors (PAI) Sales Growth and Price
10.2.1 Global Platelet aggregation inhibitors (PAI) Sales Growth (2014-2019)
10.2.2 Global Platelet aggregation inhibitors (PAI) Price (2014-2019)
10.3 Low-molecular-weight Heparin (LMWH) Sales Growth and Price
10.3.1 Global Low-molecular-weight Heparin (LMWH) Sales Growth (2014-2019)
10.3.2 Global Low-molecular-weight Heparin (LMWH) Price (2014-2019)
10.4 Direct thrombin inhibitor (DTI) Sales Growth and Price
10.4.1 Global Direct thrombin inhibitor (DTI) Sales Growth (2014-2019)
10.4.2 Global Direct thrombin inhibitor (DTI) Price (2014-2019)
10.5 Direct factor Xa inhibitors (DFXa) Sales Growth and Price
10.5.1 Global Direct factor Xa inhibitors (DFXa) Sales Growth (2014-2019)
10.5.2 Global Direct factor Xa inhibitors (DFXa) Price (2014-2019)
10.6 Vitamin K antagonists (VKA) Sales Growth and Price
10.6.1 Global Vitamin K antagonists (VKA) Sales Growth (2014-2019)
10.6.2 Global Vitamin K antagonists (VKA) Price (2014-2019)
10.7 Others Sales Growth and Price
10.7.1 Global Others Sales Growth (2014-2019)
10.7.2 Global Others Price (2014-2019)
11 Global Anticoagulants Market Segment by Application
11.1 Global Anticoagulants Sales Market Share by Application (2014-2019)
11.2 VTE Sales Growth (2014-2019)
11.3 ACS/MI Sales Growth (2014-2019)
11.4 AF Sales Growth (2014-2019)
11.5 Other Sales Growth (2014-2019)
12 Anticoagulants Market Forecast (2019-2024)
12.1 Global Anticoagulants Sales, Revenue and Growth Rate (2019-2024)
12.2 Anticoagulants Market Forecast by Regions (2019-2024)
12.2.1 North America Anticoagulants Market Forecast (2019-2024)
12.2.2 Europe Anticoagulants Market Forecast (2019-2024)
12.2.3 Asia-Pacific Anticoagulants Market Forecast (2019-2024)
12.2.4 South America Anticoagulants Market Forecast (2019-2024)
12.2.5 Middle East and Africa Anticoagulants Market Forecast (2019-2024)
12.3 Anticoagulants Market Forecast by Type (2019-2024)
12.3.1 Global Anticoagulants Sales Forecast by Type (2019-2024)
12.3.2 Global Anticoagulants Market Share Forecast by Type (2019-2024)
12.4 Anticoagulants Market Forecast by Application (2019-2024)
12.4.1 Global Anticoagulants Sales Forecast by Application (2019-2024)
12.4.2 Global Anticoagulants Market Share Forecast by Application (2019-2024)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Anticoagulants Picture
Table Product Specifications of Anticoagulants
Figure Global Sales Market Share of Anticoagulants by Types in 2018
Table Anticoag
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
